NIRVF (Nirvana Life Sciences) EBITDA Margin %: 0.00% (As of Jan. 2026)


What is Nirvana Life Sciences EBITDA Margin %?

Nirvana Life Sciences NIRVF EBITDA Margin % is 0.00% as of Jan. 2026. The stock has 3 warning signs investors should review. Among 939 Biotechnology companies, Nirvana Life Sciences ranks worse than 106496.17% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Nirvana Life Sciences's EBITDA for the three months ended in Jan. 2026 was $-0.04 Mil. Nirvana Life Sciences's Revenue for the three months ended in Jan. 2026 was $0.00 Mil. Therefore, Nirvana Life Sciences's EBITDA margin for the quarter that ended in Jan. 2026 was 0.00%.

Nirvana Life Sciences  (OTCPK:NIRVF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Nirvana Life Sciences EBITDA Margin % Related Terms

Nirvana Life Sciences EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Nirvana Life Sciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nirvana Life Sciences EBITDA Margin % Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23 Apr24 Apr25
EBITDA Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nirvana Life Sciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NIRVF vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, Nirvana Life Sciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nirvana Life Sciences EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nirvana Life Sciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Nirvana Life Sciences's EBITDA Margin % falls into.


Nirvana Life Sciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Nirvana Life Sciences's EBITDA Margin % for the fiscal year that ended in Apr. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Apr. 2025 )/Revenue (A: Apr. 2025 )
=-0.262/0
= %

Nirvana Life Sciences's EBITDA Margin % for the quarter that ended in Jan. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Jan. 2026 )/Revenue (Q: Jan. 2026 )
=-0.038/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Nirvana Life Sciences (NIRVF) has a EBITDA Margin % of 0.00% as of Jan. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nirvana Life Sciences and its competitors. According to the industry distribution chart, Nirvana Life Sciences ranks #999999 out of 939 companies in the Biotechnology industry.
Is Nirvana Life Sciences' EBITDA Margin % too high?
Nirvana Life Sciences' current EBITDA Margin % is 0.00%. Based on the distribution chart, Nirvana Life Sciences ranks #999999 out of 939 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Nirvana Life Sciences' EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nirvana Life Sciences ranks #999999 out of 939 companies for EBITDA Margin %. This places Nirvana Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Nirvana Life Sciences and its competitors. Nirvana Life Sciences's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nirvana Life Sciences stock overvalued right now?
Nirvana Life Sciences (NIRVF) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Nirvana Life Sciences (NIRVF), the current EBITDA Margin % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nirvana Life Sciences Business Description

Other Exchanges NIRV.X:Canada
Address 650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is a Canada-based company, which is engaged in the scientific research and development of therapeutic products derived from psychedelics. The Company is also focused on developing methodologies for standardized, quality-controlled extraction and purification of psychoactive compounds. The Company operates in a single reportable segment: research and development of therapeutic products derived from psychedelics. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.